Ozempic side effects investigation

November 14, 2023
Ozempic medication

In recent years, Ozempic, a drug initially approved to manage type 2 diabetes and promote weight loss, has gained immense popularity, but beneath its seemingly miraculous results lies a series of serious side effects which have led to legal actions against its manufacturers.  

Ozempic has been touted as a breakthrough in diabetes management and quickly become a household name.  

Its approval in 2017 marked a turning point in diabetes treatment, however, its popularity led to off-label use, especially for weight loss purposes.  

Aggressive marketing strategies, the cosign from countless celebrities and substantial financial investments in advertising and promotions, contributed to its widespread adoption, making it one of the most prescribed drugs in the world.

Ozempic controversy

In August 2023, a significant legal development unfolded in the U.S. District Court for the District of Louisiana. A complaint was filed against Novo Nordisk, the Danish manufacturer of Ozempic, and Eli Lilly, the creator of Mounjaro, another drug that works as a GLP-1 receptor agonist.  

The complaint alleged that the drugs, including Ozempic, increase the risk of gastroparesis and gastroenteritis, leading to severe consequences such as abdominal pain, vomiting undigested food, acid reflux, and more.  

Despite various case studies and clinical reports warning about these risks, the manufacturers had not updated their label warnings, leaving patients unaware of the potential dangers.

Ozempic side effects

Ozempic has been linked to several severe side effects such as gastroparesis and gastroenteritis, these conditions are characterized by stomach paralysis and inflammation, causing significant discomfort and health complications. The use of Ozempic has also been linked to deep vein thrombosis and aspiration, posing life-threatening risks to patients.

While Ozempic promised hope for diabetes management and weight loss, the serious side effects associated with its usage have raised significant concerns. Legal actions are underway to seek justice for those affected, emphasizing the importance of understanding the potential risks associated with pharmaceutical drugs.  

Individuals who have experienced injuries linked to Ozempic or any of the complications mentioned are urged to seek legal advice. Legal actions aim to hold the manufacturers accountable for their alleged negligence. 

Pogust Goodhead’s Mass Torts department has extensive experience representing people across the world who were harmed by unsafe products, pharmaceuticals, and medical devices. If you or someone you know has purchased or has developed severe injuries due to use of Ozempic, please click here to contact us today for a completely free and confidential consultation.

The Team

Mike Daly Pogust Goodhead

Other Investigations

US eyedrops investigation
Our Consumer and Product Liability department is investigating 26 eyedrop products that could cause infections, vision loss, or blindness.
Read More
Insights (768 × 507px) (10)
Kendamil baby formula investigation 
Parents’ concerns about babies becoming ill after baby formula maker Kendamil changed its ingredients are confirmed in a Pogust Goodhead investigation.  ...
Read More
Insignia pressure cooker recall
Insignia pressure cooker investigation 
Best Buy recalls nearly one million Insignia pressure cookers due to burn hazards 
Read More